帮助 本站公告
您现在所在的位置:网站首页 > 知识中心 > 文献详情
文献详细Journal detailed

COVID-19的临床特征及药物治疗思考
Concerns about Clinical Characteristics and Pharmacotherapeutics of COVID-19

作  者: ; ;

机构地区: 暨南大学

出  处: 《今日药学》 2020年第3期154-156,共3页

摘  要: 目的希望临床医生根据COVID-19的病理生理学特点,针对性选用治疗药物。方法综述COVID-19及SARS的相关文献,结合笔者的工作体会,总结出COVID的精准治疗方法。结果发现氧化自由基是发病的重要机理之一,细胞免疫力下降体现在疾病的全过程,而且与疾病严重性成正比,炎性因子广泛增高,但有些是正向作用(如IL-6),而有些是负向作用(如IL-8),可能是机体复杂的调节结果。结论COVID-19病人应常规抗氧化物治疗,常规使用提高细胞免疫力的药物,虽然有“炎性风暴”也不提倡应用糖皮质激素。 OBJECTIVE Clinicians are expected to select therapeutic drugs according to the pathophysiological characteristics of COVID-19.METHODS By referring to the related literature of COVID-19 and SARS,and combining the author's working experience,the precise treatment method of COVID-19 was summarized.RESULTS Oxidative radicals were found to be one of the important mechanisms of pathogenesis.Cellular immunity declines throughout the course of the disease and was proportional to the severity of the disease.Inflammatory factors were increased widely,but some were positive(such as IL-6)and some were negative(such as IL-8),which may be the result of complex regulation of the body.CONCLUSION Patients with COVID-19 should be routinely treated with antioxidants and Immunity enhancing drugs.Glucocorticoids are not recommended,atlthough the“inflammatory storm”do exist.

关 键 词: 炎症风暴 细胞免疫 糖皮质激素 新型冠状病毒肺炎

领  域: []

相关作者

作者 黄菁
作者 卢咏梅
作者 吴宇亮
作者 彭汶铎
作者 王有忠

相关机构对象

机构 华南师范大学
机构 华南师范大学体育科学学院
机构 华南师范大学生命科学学院
机构 汕头大学理学院生物系
机构 华南师范大学教育科学学院

相关领域作者